Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Unani Treatment Decreased Fibrosis and Improved Liver Functions in Decompensated Cirrhosis of Liver: A Case Series

Mohammad Akhtar Siddiqui 1 and Shabnam Ansari 1 , *
Authors Information
1 Department of Moalejat, Faculty of Medicine, Jamia Hamdard University, New Delhi, India
Article information
  • Middle East Journal of Rehabilitation and Health: April 01, 2016, 3 (2); e34195
  • Published Online: March 28, 2016
  • Article Type: Case Report
  • Received: October 31, 2015
  • Revised: February 24, 2016
  • Accepted: February 24, 2016
  • DOI: 10.17795/mejrh-34195

To Cite: Akhtar Siddiqui M, Ansari S. Unani Treatment Decreased Fibrosis and Improved Liver Functions in Decompensated Cirrhosis of Liver: A Case Series, Middle East J Rehabil Health Stud. 2016 ; 3(2):e34195. doi: 10.17795/mejrh-34195.

Abstract
Copyright © 2016, Semnan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnote
References
  • 1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371(9615): 838-51[DOI][PubMed]
  • 2. Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011; 4(6): 391-417[DOI][PubMed]
  • 3. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004; 53(5): 744-9[DOI]
  • 4. WHO . Age-standardized death rates of liver cirrhosis. 2015;
  • 5. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014; 12: 145[DOI][PubMed]
  • 6. Nancollas MP, Peimer CA, Wheeler DR, Sherwin FS. Long-term results of carpal tunnel release. J Hand Surg Br. 1995; 20(4): 470-4[PubMed]
  • 7. Amirghofran Z, Azadbakht M, Karimi MH. Evaluation of the immunomodulatory effects of five herbal plants. J Ethnopharmacol. 2000; 72(1-2): 167-72[PubMed]
  • 8. Kumar IV, Paul BN, Asthana R, Saxena A, Mehrotra S, Rajan G. Swertia chirayita mediated modulation of interleukin-1beta, interleukin-6, interleukin-10, interferon-gamma, and tumor necrosis factor-alpha in arthritic mice. Immunopharmacol Immunotoxicol. 2003; 25(4): 573-83[DOI][PubMed]
  • 9. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 1998; 27(5): 1265-74[DOI][PubMed]
  • 10. Shirwaikar A, Prabhu KS, Punitha IS. In vitro antioxidant studies of Sphaeranthus indicus (Linn). Indian J Exp Biol. 2006; 44(12): 993-6[PubMed]
  • 11. Kshirsagar P, Chavan J, Nimbalkar M, Yadav S, Dixit G, Gaikwad N. Phytochemical composition, antioxidant activity and HPLC profiles of Swertia species from Western Ghats. Nat Prod Res. 2015; 29(8): 780-4[DOI][PubMed]
  • 12. Miniaev VI, Grabel'nikov SA. The capacity of animals to purposefully alter their respiratory stereotype. Fiziol Zh. 1987; 33(3): 42-7[PubMed]
  • 13. Arulmozhi V, Krishnaveni M, Karthishwaran K, Dhamodharan G, Mirunalini S. Antioxidant and antihyperlipidemic effect of Solanum nigrum fruit extract on the experimental model against chronic ethanol toxicity. Pharmacogn Mag. 2010; 6(21): 42-50[DOI][PubMed]
  • 14. Rafiquzzaman SM, Kim EY, Kim YR, Nam TJ, Kong IS. Antioxidant activity of glycoprotein purified from Undaria pinnatifida measured by an in vitro digestion model. Int J Biol Macromol. 2013; 62: 265-72[DOI][PubMed]
  • 15. Akhtar Siddiqui M, Ansari S. Therapeutic effect of a unani formulation on hbsag in chronic hepatitis b: A case series. Asian J Pharmaceut Clin Res. 2015; 8(5)
  • 16. Ali A, Shyum Naqvi SB, Gauhar S, Saeed R. Anti-inflammatory and analgesic activities of ethanolic extract of Sphaeranthus indicus Linn. Pak J Pharm Sci. 2011; 24(3): 405-9[PubMed]
  • 17. Ramachandran S. Review on Sphaeranthus indicus Linn. (Kottaikkarantai). Pharmacogn Rev. 2013; 7(14): 157-69[DOI][PubMed]
  • 18. Mukherjee S, Sur A, Maiti BR. Hepatoprotective effect of Swertia chirata on rat. Indian J Exp Biol. 1997; 35(4): 384-8[PubMed]
  • 19. Karan M, Vasisht K, Handa SS. Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats. Phytother Res. 1999; 13(2): 95-101[DOI][PubMed]
  • 20. Zhou NJ, Geng CA, Huang XY, Ma YB, Zhang XM, Wang JL, et al. Anti-hepatitis B virus active constituents from Swertia chirayita. Fitoterapia. 2015; 100: 27-34[DOI][PubMed]
  • 21. Tamanna SA. Effect of Jigreen on Patients Suffering from Hepatitis B. Proceeding of the National Seminar on Reasearch Methodology in Unani Medicine. 1995;
  • 22. Ansari S, Siddiqui A, Nikhat S, Mushtaq S. Gilbert's syndrome- a case with interpretation and management in unani medicine. Int J Pharmacognosy. 2015; 2(2): 98-101[DOI]
  • 23. Wesolowska A, Nikiforuk A, Michalska K, Kisiel W, Chojnacka-Wojcik E. Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. J Ethnopharmacol. 2006; 107(2): 254-8[DOI][PubMed]
  • 24. Saxena M, Shakya AK, Sharma N, Shrivastava S, Shukla S. Therapeutic efficacy of Rosa damascena Mill. on acetaminophen-induced oxidative stress in albino rats. J Environ Pathol Toxicol Oncol. 2012; 31(3): 193-201[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments